A detailed history of Ubs Asset Management Americas Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 9,233,933 shares of ABT stock, worth $1.07 Billion. This represents 0.28% of its overall portfolio holdings.

Number of Shares
9,233,933
Previous 9,811,210 5.88%
Holding current value
$1.07 Billion
Previous $1.02 Billion 3.26%
% of portfolio
0.28%
Previous 0.3%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $57.8 Million - $68.2 Million
-577,277 Reduced 5.88%
9,233,933 $1.05 Billion
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $287 Million - $320 Million
2,848,172 Added 40.9%
9,811,210 $1.02 Billion
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $6.79 Million - $7.5 Million
-62,034 Reduced 0.88%
6,963,038 $791 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $33.4 Million - $40.9 Million
-370,609 Reduced 5.01%
7,025,072 $773 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $946 Million - $1.14 Billion
-9,902,729 Reduced 57.25%
7,395,681 $716 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $871 Million - $1.03 Billion
8,995,652 Added 108.35%
17,298,410 $1.75 Billion
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $86.3 Million - $101 Million
908,048 Added 12.28%
8,302,758 $912 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $19.8 Million - $23 Million
-205,115 Reduced 2.7%
7,394,710 $716 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $53.2 Million - $64.3 Million
521,341 Added 7.37%
7,599,825 $826 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $11.8 Million - $14.4 Million
-103,844 Reduced 1.45%
7,078,484 $838 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $156 Million - $191 Million
-1,348,358 Reduced 15.81%
7,182,328 $1.01 Billion
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $99.7 Million - $110 Million
854,744 Added 11.14%
8,530,686 $1.01 Billion
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $120 Million - $141 Million
-1,134,092 Reduced 12.87%
7,675,942 $890 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $44 Million - $51.9 Million
-404,423 Reduced 4.39%
8,810,034 $1.06 Billion
Q4 2020

Mar 01, 2021

BUY
$105.0 - $114.42 $74.2 Million - $80.9 Million
706,896 Added 8.31%
9,214,457 $1.01 Billion
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $11.2 Million - $13.6 Million
121,985 Added 1.45%
8,507,561 $926 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $222 Million - $285 Million
-2,903,886 Reduced 25.72%
8,385,576 $767 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $92.4 Million - $135 Million
1,471,198 Added 14.98%
11,289,462 $891 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $51.1 Million - $56.9 Million
-651,067 Reduced 6.22%
9,818,264 $853 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $46.5 Million - $50.4 Million
567,697 Added 5.73%
10,469,331 $876 Million
Q2 2019

Aug 15, 2019

SELL
$72.88 - $85.0 $54.1 Million - $63.1 Million
-742,604 Reduced 6.98%
9,901,634 $0
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $26.1 Million - $31.6 Million
394,774 Added 3.85%
10,644,238 $0
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $122 Million - $138 Million
1,854,616 Added 22.09%
10,249,464 $741 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $9.08 Million - $11 Million
-149,338 Reduced 1.75%
8,394,848 $0
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $26 Million - $28.7 Million
451,554 Added 5.58%
8,544,186 $0
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $38.3 Million - $43.4 Million
681,392 Added 9.19%
8,092,632 $0
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $40.3 Million - $43.2 Million
-751,008 Reduced 9.2%
7,411,240 $0
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $392 Million - $438 Million
8,162,248
8,162,248 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.